Table of Contents Author Guidelines Submit a Manuscript
Journal of Healthcare Engineering
Volume 5, Issue 1, Pages 23-54
http://dx.doi.org/10.1260/2040-2295.5.1.23
Research Article

A Quadruply-Asymmetric Sigmoid to Describe the Insulin-Glucose Relationship during Intravenous Insulin Infusion

Daniel T. Braithwaite,1 Guillermo E. Umpierrez,2 and Susan S. Braithwaite3

1Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, IL, USA
2Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, Georgia, USA
3Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA

Received 1 July 2013; Accepted 1 November 2013

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. E. Umpierrez, S. D. Isaacs, N. Bazargan, X. You, L. M. Thaler, and A. E. Kitabchi, “Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes,” J Clin Endocrinol Metab, vol. 87, no. 3, pp. 978–82, 2002. View at Google Scholar
  2. D. E. Griesdale, R. J. de Souza, R. M. van Dam et al., “Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data,” CMAJ, vol. 180, no. 8, pp. 821–827, 2009. View at Google Scholar
  3. G. Van den Berghe, P. Wouters, F. Weekers et al., “Intensive insulin therapy in critically ill patients,” N Engl J Med, vol. 345, no. 19, pp. 1359–1367, 2001. View at Google Scholar
  4. S. Finfer, D. R. Chittock, S. Y. Su et al., “Intensive versus conventional glucose control in critically ill patients,” N Engl J Med, vol. 360, no. 13, pp. 1283–1297, 2009. View at Google Scholar
  5. E. S. Moghissi, MT. Korytkowski, M. DiNardo et al., “American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control,” Endocr Pract, vol. 15, no. 4, pp. 353–369, 2009. View at Google Scholar
  6. “Executive summary: Standards of medical care in diabetes—2013,” Diabetes Care, vol. 36, Suppl 1, pp. S4–S10, 2013.
  7. J. Jacobi, N. Bircher, J. Krinsley et al., “Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients,” Crit Care Med, vol. 40, no. 12, pp. 3251–3276, 2012. View at Google Scholar
  8. A. E. Kitabchi, G. E. Umpierrez, J. M. Miles, and J. N. Fisher, “Hyperglycemic crises in adult patients with diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1335–1343, 2009. View at Google Scholar
  9. M. H. Murad, J. A. Coburn, F. Coto-Yglesias et al., “Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis,” J Clin Endocrinol Metab, vol. 97, no. 1, pp. 49–58, 2012. View at Google Scholar
  10. G. E. Umpierrez, R. Hellman, M. T. Korytkowski et al., “Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline,” J Clin Endocrinol Metab, vol. 97, no. 1, pp. 16–38, 2012. View at Google Scholar
  11. American Diabetes Association Workgroup on Hypoglycemia, “Defining and Reporting Hypoglycemia in Diabetes: Areport from the American Diabetes Association Workgroup on Hypoglycemia,” Diabetes Care, vol. 28, no. 5, pp. 1245–1249, 2005. View at Google Scholar
  12. E. R. Seaquist, J. Anderson, B. Childs et al., “Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society,” Diabetes Care, vol. 36, no. 5, pp. 1384–1395, 2013. View at Google Scholar
  13. G. Van den Berghe, A. Wilmer, I. Milants et al., “Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm,” Diabetes, vol. 55, no. 11, pp. 3151–3159, 2006. View at Google Scholar
  14. T. M. Vriesendorp, S. van Santen, J. H. DeVries et al., “Predisposing factors for hypoglycemia in the intensive care unit,” Crit Care Med, vol. 34, no. 1, pp. 96–101, 2006. View at Google Scholar
  15. J. S. Krinsley and A. Grover, “Severe hypoglycemia in critically ill patients: risk factors and outcomes,” Crit Care Med, vol. 35, no. 10, pp. 2262–2267, 2007. View at Google Scholar
  16. M. Egi, R. Bellomo, E. Stachowski et al., “Hypoglycemia and outcome in critically ill patients,” Mayo Clin Proc, vol. 85, no. 3, pp. 217–224, 2010. View at Google Scholar
  17. S. E. Siegelaar, J. Hermanides, H. M. Oudemans-van Straaten et al., “Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study,” Crit Care, vol. 14, no. 6, p. R224, 2010. View at Google Scholar
  18. R. Garg, A. Jarry, and M. Pendergrass, “Delay in blood glucose monitoring during an insulin infusion protocol is associated with increased risk of hypoglycemia in intensive care units,” J Hosp Med, vol. 4, no. 6, pp. E5–E7, 2009. View at Google Scholar
  19. R. Juneja, C. Roudebush, S. Nasraway et al., “Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time,” Critical Care, vol. 13, no. 5, p. R163, 2009. View at Google Scholar
  20. S. Yamashita, E. Ng, F. Brommecker, J. Silverberg, and N. K. Adhikari, “Implementation of the glucommander method of adjusting insulin infusions in critically ill patients,” Can J Hosp Pharm, vol. 64, no. 5, pp. 333–339, 2011. View at Google Scholar
  21. M. Horibe, B. G. Nair, G. Yurina, M. B. Neradilek, and I. Rozet, “A novel computerized fading memory algorithm for glycemic control in postoperative surgical patients,” Anesth Analg, vol. 115, no. 3, pp. 580–587, 2012. View at Google Scholar
  22. M. R. Marvin, S. E. Inzucchi, and B. J. Besterman, “Computerization of the yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin,” Diabetes Technol Ther, vol. 15, no. 3, pp. 246–252, 2013. View at Google Scholar
  23. H. Bellam and S. S. Braithwaite, “Hospital hypoglycemia: from observation to action,” Insulin Journal, vol. 5, no. 1, pp. 16–36, 2010. View at Google Scholar
  24. R. Devi, G. Selvakumar, L. Clark, C. Downer, and S. S. Braithwaite, “A dose-defining insulin algorithm for attainment and maintenance of glycemic targets during therapy of hyperglycemic crises,” Diabetes Management, vol. 1, no. 4, pp. 397–412, 2011. View at Google Scholar
  25. R. Devi, T. Zohra, B. S. Howard, and S. S. Braithwaite, Diabetes Technol Ther, vol. 16, no. 4, pp. 208–218, 2014. View at Publisher · View at Google Scholar
  26. S. S. Braithwaite, H. Godara, J. Song, B. A. Cairns, S. W. Jones, and G. E. Umpierrez, “Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion,” J Diabetes Sci Technol, vol. 3, no. 4, pp. 835–856, 2009. View at Google Scholar
  27. M. E. Wilinska and M. Nodale, “An evaluation of I, Pancreas algorithm performance in silico,” J Diabetes Sci Technol, vol. 3, no. 4, pp. 857–62, 2009. View at Google Scholar
  28. P. C. Davidson, H. R. Hebblewhite, R. D. Steed, and B. W. Bode, “Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio,” Endocr Pract, vol. 14, no. 9, pp. 1095–1101, 2008. View at Google Scholar
  29. F. J. Richards, “A Flexible Growth Function for Empirical Use,” Journal of Experimental Botany, vol. 10, no. 2, pp. 290–301, 1959. View at Google Scholar
  30. Wolfram Research I. Mathematicaed., Wolfram Research, Inc, Champaign, IL, 9.0 edition, 2013.
  31. B. Kovatchev, S. Patek, E. Dassau et al., “Control to range for diabetes: functionality and modular architecture,” J Diabetes Sci Technol, vol. 3, no. 5, pp. 1058–1065, 2009. View at Google Scholar
  32. S. D. Patek, L. Magni, E. Dassau et al., “Modular closed-loop control of diabetes,” IEEE Trans Biomed Eng, vol. 59, no. 11, pp. 2986–2999, 2012. View at Google Scholar
  33. B. Zeide, “Analysis of Growth Equations,” Forest Science, vol. 39, no. 3, pp. 594–616, 1993. View at Google Scholar
  34. C. Birch, “A New Generalized Logistic Sigmoid Growth Equation Compared with the Richards Growth Equation,” Annals of Botany, vol. 83, no. 6, pp. 713–23, 1999. View at Google Scholar
  35. K. Dungan, J. Chapman, S. S. Braithwaite, and J. Buse, “Glucose measurement: confounding issues in setting targets for in patient management,” Diabetes Care, vol. 30, no. 2, pp. 403–409, 2007. View at Google Scholar
  36. J. G. Chase, G. Shaw, A. Le Compte et al., “Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change,” Crit Care, vol. 12, no. 2, p. R49, 2008. View at Google Scholar
  37. S. J. Russell, F. H. El-Khatib, D. M. Nathan, K. L. Magyar, J. Jiang, and E. R. Damiano, “Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas,” Diabetes Care, vol. 35, no. 11, pp. 2148–2155, 2012. View at Google Scholar
  38. S. H. Song, S. S. McIntyre, H. Shah, J. D. Veldhuis, P. C. Hayes, and P. C. Butler, “Direct Measurement of Pulsatile Insulin Secretion from the Portal Vein in Human Subjects,” J Clin Endocrinol Metab, vol. 85, no. 12, pp. 4491–4499, 2000. View at Google Scholar
  39. N. Pørksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz, “Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes,” Diabetes, vol. 51, suppl 1, pp. S245–S254, 2002. View at Google Scholar
  40. R. Hovorka, J. Kremen, J. Blaha et al., “Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial,” J Clin Endocrinol Metab, vol. 92, no. 8, pp. 2960–2964, 2007. View at Google Scholar
  41. P. Kopecky, M. Mraz, J. Blaha et al., “The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU,” Biomed Res Int, vol. 2013, Article ID 186439, 2013. View at Google Scholar
  42. T. Van Herpe, D. Mesotten, P. J. Wouters et al., “LOGIC-Insulin Algorithm-Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial,” Diabetes Care, vol. 36, no. 2, pp. 188–194, 2013. View at Google Scholar
  43. E. M. Brown, “Four-Parameter Model of the Sigmoidal Relationship between Parathyroid Hormone Release and Extracellular Calcium Concentration in Normal and Abnormal Parathyroid Tissue,” J Clin Endocrinol Metab, vol. 56, no. 3, pp. 572–581, 1983. View at Google Scholar
  44. S. S. Braithwaite and S. Clement, “Algorithms for intravenous insulin delivery,” Curr Diabetes Rev, vol. 4, no. 3, pp. 258–268, 2008. View at Google Scholar
  45. P. C. Davidson, R. D. Steed, and B. W. Bode, “Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120, 618 h of operation,” Diabetes Care, vol. 28, no. 10, pp. 2418–2423, 2005. View at Google Scholar
  46. S. J. McNulty and P. English, “Euglycaemic diabetic ketoacidosis,” Practical Diabetes International, vol. 19, no. 2, p. 63, 2002. View at Google Scholar
  47. F. Joseph, L. Anderson, N. Goenka, and J. Vora, “Starvation-induced true diabetic euglycemic ketoacidosis in severe depression,” J Gen Intern Med, vol. 24, no. 1, pp. 129–131, 2009. View at Google Scholar
  48. J. B. Boord, M. Sharifi, R. A. Greevy et al., “Computer-based insulin infusion protocol improves glycemia control over manual protocol,” J Am Med Inform Assoc, vol. 14, no. 3, pp. 278–287, 2007. View at Google Scholar
  49. K. L. Hermayer, D. E. Neal, T. V. Hushion et al., “Outcomes of a Cardiothoracic Intensive Care Web-Based Online Intravenous Insulin Infusion Calculator Study at a Medical University Hospital,” Diabetes Technology & Therapeutics, vol. 9, pp. 523–534, 2007. View at Google Scholar
  50. M. J. Dortch, N. T. Mowery, A. Ozdas et al., “A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit,” JPEN J Parenter Enteral Nutr, vol. 32, no. 1, pp. 18–27, 2008. View at Google Scholar
  51. A. H. Morris, J. Orme Jr., J. D. Truwit et al., “A replicable method for blood glucose control in critically Ill patients,” Crit Care Med, vol. 36, no. 6, pp. 1787–1795, 2008. View at Google Scholar
  52. L. Saager, G. L. Collins, B. Burnside et al., “A randomized study in diabetic patients undergoing cardiac surgery comparing computer-guided glucose management with a standard sliding scale protocol,” J Cardiothorac Vasc Anesth, vol. 22, no. 3, pp. 377–382, 2008. View at Google Scholar
  53. A. Krikorian, F. Ismail-Beigi, and E. S. Moghissi, “Comparisons of different insulin infusion protocols: a review of recent literature,” Curr Opin Clin Nutr Metab Care, vol. 13, no. 2, pp. 198–204, 2010. View at Google Scholar
  54. C. A. Newton, D. Smiley, B. W. Bode et al., “A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms,” J Hosp Med, vol. 5, no. 8, pp. 432–437, 2010. View at Google Scholar
  55. S. E. Crockett, J. Suarez-Cavelier, K. D. Accola et al., “Risk of postoperative hypoglycemia in cardiovascular surgical patients receiving computer-based versus paper-based insulin therapy,” Endocr Pract, vol. 18, no. 4, pp. 529–537, 2012. View at Google Scholar
  56. A. Lee, B. Faddoul, A. Sowan, K. L. Johnson, K. D. Silver, and V. Vaidya, “Computerisation of a paper-based intravenous insulin protocol reduces errors in a prospective crossover simulated tight glycaemic control study,” Intensive Crit Care Nurs, vol. 26, no. 3, pp. 161–168, 2010. View at Google Scholar
  57. C. Dumont and C. Bourguignon, “Effect of a Computerized Insulin Dose Calculator on the Process of Glycemic Control,” American Journal of Critical Care, vol. 21, no. 2, pp. 106–115, 2012. View at Google Scholar
  58. C. Olinghouse, “Development of a computerized intravenous insulin application (AutoCal) at Kaiser Permanente North west, integrated into Kaiser Permanente Health Connect: impact on safety and nursing workload,” Perm J, vol. 16, no. 3, pp. 67–70, 2012. View at Google Scholar
  59. R. Prager, P. Wallace, and J. M. Olefsky, “In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects,” J Clin Invest, vol. 78, no. 2, pp. 472–481, 1986. View at Google Scholar
  60. S. Mudaliar, P. Mohideen, R. Deutsch et al., “Intravenous Glargine and Regular Insulin Have Similar Effects on Endogenous Glucose Output and Peripheral Activation/Deactivation Kinetic Profiles,” Diabetes Care, vol. 25, no. 9, pp. 1597–1602, 2002. View at Google Scholar
  61. C. A. Ihlo, T. Lauritzen, J. Sturis, O. Skyggebjerg, J. S. Christiansen, and T. Laursen, “Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart,” Diabet Med, vol. 28, no. 2, pp. 230–236, 2011. View at Google Scholar